BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

460 related articles for article (PubMed ID: 19372354)

  • 1. The effect of peripherally administered CDP-choline in an acute inflammatory pain model: the role of alpha7 nicotinic acetylcholine receptor.
    Gurun MS; Parker R; Eisenach JC; Vincler M
    Anesth Analg; 2009 May; 108(5):1680-7. PubMed ID: 19372354
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The antinociceptive effects of centrally administered CDP-choline on acute pain models in rats: the involvement of cholinergic system.
    Hamurtekin E; Gurun MS
    Brain Res; 2006 Oct; 1117(1):92-100. PubMed ID: 16942753
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Possible involvement of supraspinal opioid and GABA receptors in CDP-choline-induced antinociception in acute pain models in rats.
    Hamurtekin E; Bagdas D; Gurun MS
    Neurosci Lett; 2007 Jun; 420(2):116-21. PubMed ID: 17531379
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The antihyperalgesic effect of cytidine-5'-diphosphate-choline in neuropathic and inflammatory pain models.
    Bagdas D; Sonat FA; Hamurtekin E; Sonal S; Gurun MS
    Behav Pharmacol; 2011 Sep; 22(5-6):589-98. PubMed ID: 21836465
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Preclinical evidence for the antihyperalgesic activity of CDP-choline in oxaliplatin-induced neuropathic pain.
    Kanat O; Bagdas D; Ozboluk HY; Gurun MS
    J BUON; 2013; 18(4):1012-8. PubMed ID: 24344031
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antinociceptive effects of choline against acute and inflammatory pain.
    Wang Y; Su DM; Wang RH; Liu Y; Wang H
    Neuroscience; 2005; 132(1):49-56. PubMed ID: 15780465
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Peripherally mediated antinociception of the mu-opioid receptor agonist 2-[(4,5alpha-epoxy-3-hydroxy-14beta-methoxy-17-methylmorphinan-6beta-yl)amino]acetic acid (HS-731) after subcutaneous and oral administration in rats with carrageenan-induced hindpaw inflammation.
    Bileviciute-Ljungar I; Spetea M; Guo Y; Schütz J; Windisch P; Schmidhammer H
    J Pharmacol Exp Ther; 2006 Apr; 317(1):220-7. PubMed ID: 16339394
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ghrelin inhibits inflammatory pain in rats: involvement of the opioid system.
    Sibilia V; Lattuada N; Rapetti D; Pagani F; Vincenza D; Bulgarelli I; Locatelli V; Guidobono F; Netti C
    Neuropharmacology; 2006 Sep; 51(3):497-505. PubMed ID: 16759671
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Choline, CDP-choline or phosphocholine increases plasma glucagon in rats: involvement of the peripheral autonomic nervous system.
    Cansev M; Ilcol YO; Yilmaz MS; Hamurtekin E; Ulus IH
    Eur J Pharmacol; 2008 Jul; 589(1-3):315-22. PubMed ID: 18561911
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cardiovascular effects of intracerebroventricularly injected CDP-choline in normotensive and hypotensive animals: the involvement of cholinergic system.
    Savci V; Cavun S; Goktalay G; Ulus IH
    Naunyn Schmiedebergs Arch Pharmacol; 2002 May; 365(5):388-98. PubMed ID: 12012025
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inducible nitric oxide synthase and cyclooxygenase-2 participate in anti-inflammatory and analgesic effects of the natural marine compound lemnalol from Formosan soft coral Lemnalia cervicorni.
    Jean YH; Chen WF; Duh CY; Huang SY; Hsu CH; Lin CS; Sung CS; Chen IM; Wen ZH
    Eur J Pharmacol; 2008 Jan; 578(2-3):323-31. PubMed ID: 17916350
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Studies with ketamine and alfentanil following Freund's complete adjuvant-induced inflammation in rats.
    Edwards SR; Mather LE; Smith MT
    Clin Exp Pharmacol Physiol; 2007; 34(5-6):414-20. PubMed ID: 17439409
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antishock effect of anisodamine involves a novel pathway for activating alpha7 nicotinic acetylcholine receptor.
    Liu C; Shen FM; Le YY; Kong Y; Liu X; Cai GJ; Chen AF; Su DF
    Crit Care Med; 2009 Feb; 37(2):634-41. PubMed ID: 19114896
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Increased tumor necrosis factor-alpha and prostaglandin E2 concentrations in the cerebrospinal fluid of rats with inflammatory hyperalgesia: the effects of analgesic drugs.
    Bianchi M; Martucci C; Ferrario P; Franchi S; Sacerdote P
    Anesth Analg; 2007 Apr; 104(4):949-54. PubMed ID: 17377112
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of hydroxytyrosol-20 on carrageenan-induced acute inflammation and hyperalgesia in rats.
    Gong D; Geng C; Jiang L; Cao J; Yoshimura H; Zhong L
    Phytother Res; 2009 May; 23(5):646-50. PubMed ID: 19067390
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The peripheral antinociceptive effects of endomorphin-1 and kynurenic acid in the rat inflamed joint model.
    Mecs L; Tuboly G; Nagy E; Benedek G; Horvath G
    Anesth Analg; 2009 Oct; 109(4):1297-304. PubMed ID: 19762760
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antinociceptive effects of meptazinol and its isomers on carrageenan-induced thermal hyperalgesia in rats.
    Wang PF; Zhang YQ; Qiu ZB; Zhao ZQ
    Sheng Li Xue Bao; 2004 Jun; 56(3):295-300. PubMed ID: 15224140
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evaluation of antinociceptive and anti-inflammatory effects of venlafaxine in the rat.
    Aricioğlu F; Buldanlioğlu U; Salanturoğlu G; Ozyalçin NS
    Agri; 2005 Oct; 17(4):41-6. PubMed ID: 16552649
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Modulation of peripheral inflammatory pain thresholds by M(1) and nicotinic receptor antagonists.
    Motta PG; Perez AC; Alves DP; Duarte ID
    Pharmacology; 2011; 88(5-6):309-15. PubMed ID: 22104294
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Anti-hyperalgesic and anti-inflammatory effects of ketorolac tromethamine gel using pulsed ultrasound in inflamed rats.
    Yang JH; Kim TY; Lee JH; Yoon SW; Yang KH; Shin SC
    Arch Pharm Res; 2008 Apr; 31(4):511-7. PubMed ID: 18449510
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 23.